|
Trackwise#: (b)(4) updated sections: b4, g4, g7, h2, h3, h6, h10 the device was returned to the factory for evaluation on (b)(6) 2023.An investigation was conducted on (b)(6) 2023.A visual inspection was conducted.Signs of clinical use and and no evidence of blood was observed.The flow volume controller was inspected and was observed to have no visual or physical defects.The controller was able to be rolled with no physical difficulties.The spike chamber was returned filled with saline.A microscopic evaluation was conducted.The flow path through the y-connector was observed to be clear.The glue connecting the shaft connecter and tubing was observed to be placed correctly.No occlusions caused by the glue were observed.The tip of the blower mister was observed to be intact with no visual defects observed.A functional test was performed.The returned iv spike and chamber was removed.A syringe was filled with water and connected to the saline port of the iv luer lock connection.The plunger of the syringe was depressed and water was observed to come out of the atraumatic tip with normal flow and no blockages.The braided tubing was connected to a co2 source, not exceeding 50 psi (344 kpa), and co2 gas was able to flow through the iv tubing.The sound of co2 gas was heard at the atraumatic tip while coming out of the tube.The syringe was depressed at a steady rate and the irrigation mist was observed to flow out of the tip as expected.Based on the returned condition of the device, the reported failure "improper flow or infusion" was not confirmed.The lot # 96255710 history record review was completed.There were no ncmrs, rework, or deviations documented for the reported lot number.Based on the lhr review results, it was determined that there is no relation between the batch manufacturing process and the reported failure.
|